$TOI

Chernett Jorey purchased $78K of TOI

Chernett Jorey purchased 12,000 shares of Starling Oncology, Inc. (TOI) at $6.54 on 2026-08-14.

Original reporting
SEC EDGAR · Chernett Jorey
Published Aug 17, 2026, 2:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 2:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TOI
Bullish
medium confidence
Mentioned
$TOI
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TOIBullishLow
01

Why it matters

The newest fact is the specific open-market purchase by Chernett Jorey (10% owner) of 12,000 shares at $6.54, filed on 2026-08-17.

02

Market read

Traders may note the insider buy as a small sentiment input, but there is no accompanying fundamental update in the text.

03

What to watch

The article does not confirm whether the purchase was part of a broader pattern, nor does it provide post-transaction performance context or any concurrent corporate news.

Relevance 4/10Novelty 5/10Timing: filed 2026-08-17, transaction dated 2026-08-14

Background

This is an SEC Form 4 insider transaction disclosure for Starling Oncology, Inc. (TOI).

Company-level read

Ticker impact

$TOIBullishMedium confidence
Context

Starling Oncology insider Chernett Jorey bought 12,000 shares at $6.54 on 2026-08-14, totaling $78,480, per Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.

Evidence & confidence

Form 4 insider buys can influence sentiment, but the article provides no new company fundamentals (no guidance, trial, deal, or regulatory update). The transaction size is moderate and lacks a 10b5-1 plan context.

Market effects

No sector-level implications are provided; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine liquidity or diversification-related and do not necessarily signal improved fundamentals, especially without a stated rationale.

Key entities

  • Starling Oncology, Inc.

    Company whose insider transaction is disclosed on Form 4 (TOI).

  • Chernett Jorey

    10% owner who purchased 12,000 shares at $6.54 on 2026-08-14.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNIMedAI 9/10

Canadian Stocks to Buy Today and Hold for the Next 7 Years

The article highlights three Canadian stocks for a 7-year hold: Canadian National Railway (CNR), Alimentation Couche-Tard (ATD), and Topicus.com (TOI). CNR reported Q1 revenue of $4.4B and free cash flow of $900M (+44% YoY) and repurchased $869M of shares. ATD’s fiscal Q3 adjusted EPS rose 19.1% to US$0.81; merchandise and service revenue grew 8.7% to US$5.8B. Topicus reported Q1 2026 revenue up 23% to €435.7M and free cash flow to shareholders up 2% to €165.4M.

$MWHMed

AMERICAN SECURITIES LLC sold 7,939,153 shares of MWH (indirect holdings)

AMERICAN SECURITIES LLC sold 7,939,153 indirectly-held shares of SOLV Energy, Inc. (MWH) on 2026-08-19. Filed jointly with ASP Endeavor Investco LP (10% owner), ASP SOLV Aggregator LP (10% owner), ASP VIII Alternative Investments, L.P. (10% owner), American Securities Associates VIII, LLC (10% owner), AS/ASP VIII Co-Investor, LLC (10% owner), ASP Manager Corp. (10% owner), American Securities Partners VIII(B), L.P. (10% owner), ASP VIII SOLV Holdings LP (10% owner) and ASP VIII CSE Holdings LP (10% owner).